{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T06:32:25Z","timestamp":1784874745395,"version":"3.55.0"},"reference-count":18,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":435,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T00:00:00Z","timestamp":1722902400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007132","name":"Otsuka Pharmaceutical Co., Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007132","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007132","name":"Otsuka Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007132","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>To help establish optimized treatment strategies for congestion in patients with acute heart failure, this study aimed to provide a detailed summary of real-world diuretic use in hospitalized patients with heart failure requiring urgent therapy in Japan.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>This observational study used a Japanese medical records database to extract data of patients admitted to hospital with a heart failure diagnosis and an intravenous diuretic prescription from the day before admission to 2 days after. Time from hospital visit to first dose, second dose, and maximum dose of intravenous diuretics were determined. Patients were grouped according to whether they received diuretic modification, defined as an intravenous diuretic dose increase or concomitant use of other diuretics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Overall, 1577 patients were included in the study (without diuretic modification, n = 1140 [72.3%]; with diuretic modification, n = 437 [27.7%]). The study population was 49.5% female (n = 780) and the mean age \u00b1 standard deviation was 80.1 \u00b1 12.7 years. Intravenous diuretic treatment was received within 1 h of their hospital visit in 43.5% of patients (686\/1577) and \u22642 h in 16.4% of patients (258\/1577). Among 437 patients with an inadequate response following their first dose, 42.1% received an intravenous dose titration, 56.5% received combination diuretics, and 1.4% received both. Over half of the patients (59.0% [258\/437]) with diuretic modification received it after the first 24 h of the hospital visit. The median time from hospital visit to first dose titration was similar to time to first combination diuretic use (18.6 h and 17.0 h, respectively). The mean \u00b1 standard deviation duration of intravenous diuretic use was significantly longer for patients with versus without diuretic modification (6.3 \u00b1 5.2 vs. 3.7 \u00b1 3.2 days), and a significantly greater proportion of patients (44.6% [195\/437] vs. 35.0% [399\/1140]) received repeated intravenous diuretic administration. Other characteristics\/outcomes of intravenous diuretic use were similar with versus without diuretic modification, including in-hospital death (15.6% [68\/437] vs. 13.9% [159\/1140]) and mean \u00b1 standard deviation length of hospitalization (21.9 \u00b1 14.7 days vs. 22.1 \u00b1 21.2 days).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In Japan, real-world patterns of intravenous diuretic administration for patients with heart failure remains far from the time-sensitive approach recommended in Japanese, European, and United States guidelines.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.15005","type":"journal-article","created":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T05:54:23Z","timestamp":1722923663000},"page":"4061-4070","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Time to Intravenous Diuretic Administration in Patients Hospitalized with Heart Failure: An Observational Study"],"prefix":"10.1093","volume":"11","author":[{"given":"Yasuyuki","family":"Shiraishi","sequence":"first","affiliation":[{"name":"Department of Cardiology, Keio University School of Medicine , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Kurita","sequence":"additional","affiliation":[{"name":"Medical Affairs, Otsuka Pharmaceutical Co., Ltd. , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromasa","family":"Mori","sequence":"additional","affiliation":[{"name":"Medical Affairs, Otsuka Pharmaceutical Co., Ltd. , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyuki","family":"Ooishi","sequence":"additional","affiliation":[{"name":"Medical Affairs, Otsuka Pharmaceutical Co., Ltd. , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyuki","family":"Matsukawa","sequence":"additional","affiliation":[{"name":"Medical Affairs, Otsuka Pharmaceutical Co., Ltd. , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,8,6]]},"reference":[{"key":"2026012113121386900_ehf215005-bib-0001","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1253\/circj.CJ-19-0342","article-title":"Japanese Circulation Society and the Japanese Heart Failure Society Joint Working Group. JCS 2017\/JHFS 2017 guideline on diagnosis and treatment of acute and chronic heart failure - digest version","volume":"83","author":"Tsutsui","year":"2019","journal-title":"Circ J"},{"key":"2026012113121386900_ehf215005-bib-0002","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"2026012113121386900_ehf215005-bib-0003","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.008687","article-title":"9-year trend in the management of acute heart failure in Japan: A report from the National Consortium of Acute Heart Failure Registries","volume":"7","author":"Shiraishi","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"2026012113121386900_ehf215005-bib-0004","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1253\/circj.cj-13-0187","article-title":"ATTEND Investigators. Clinical features and outcome in hospitalized heart failure in Japan (from the ATTEND registry)","volume":"77","author":"Sato","year":"2013","journal-title":"Circ J"},{"key":"2026012113121386900_ehf215005-bib-0005","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/ejhf.2708","article-title":"Association of time-to-intravenous furosemide with mortality in acute heart failure: Data from REPORT-HF","volume":"25","author":"Ouwerkerk","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"2026012113121386900_ehf215005-bib-0006","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1016\/j.jacc.2017.04.042","article-title":"Time-to-furosemide treatment and mortality in patients hospitalized with acute heart failure","volume":"69","author":"Matsue","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026012113121386900_ehf215005-bib-0007","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1016\/j.jacc.2019.08.001","article-title":"2019 ACC expert consensus decision pathway on risk assessment, management, and clinical trajectory of patients hospitalized with heart failure: A report of the American College of Cardiology Solution Set Oversight Committee","volume":"74","author":"Hollenberg","year":"2019","journal-title":"J Am Coll Cardiol."},{"key":"2026012113121386900_ehf215005-bib-0008","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1002\/ehf2.13139","article-title":"Time-sensitive approach in the management of acute heart failure","volume":"8","author":"Shiraishi","year":"2021","journal-title":"ESC Heart Fail"},{"key":"2026012113121386900_ehf215005-bib-0009","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.jchf.2020.05.013","article-title":"In-hospital therapy for heart failure with reduced ejection fraction in the United States","volume":"8","author":"Greene","year":"2020","journal-title":"JACC Heart Fail"},{"key":"2026012113121386900_ehf215005-bib-0010","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nrcardio.2014.215","article-title":"Diuretic response in acute heart failure-pathophysiology, evaluation, and therapy","volume":"12","author":"ter Maaten","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"2026012113121386900_ehf215005-bib-0011","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s11897-019-0424-1","article-title":"Diuretic resistance in heart failure","volume":"16","author":"Gupta","year":"2019","journal-title":"Curr Heart Fail Rep"},{"key":"2026012113121386900_ehf215005-bib-0012","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1253\/circrep.CR-22-0091","article-title":"Real-world intravenous diuretic use to treat congestion in patients with heart failure - An observational study using a research database","volume":"5","author":"Shiraishi","year":"2023","journal-title":"Circ Rep"},{"key":"2026012113121386900_ehf215005-bib-0013","doi-asserted-by":"publisher","first-page":"206","DOI":"10.14740\/cr1390","article-title":"Factors influencing thirty-day readmission rate in patients with heart failure exacerbation","volume":"13","author":"Alsamman","year":"2022","journal-title":"Cardiol Res"},{"key":"2026012113121386900_ehf215005-bib-0014","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.12742","article-title":"The impact of door to diuretic time in acute heart failure on hospital length of stay and in-patient mortality","volume":"13","author":"Iqbal","year":"2021","journal-title":"Cureus"},{"key":"2026012113121386900_ehf215005-bib-0015","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.123.031179","article-title":"Temporal trends in heart failure management and outcomes: insights from a Japanese multicenter registry of tertiary care centers","volume":"12","author":"Nakamaru","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"2026012113121386900_ehf215005-bib-0016","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1253\/circj.CJ-17-1386","article-title":"Demographics, management, and in-hospital outcome of hospitalized acute heart failure syndrome patients in contemporary real clinical practice in Japan - Observations from the prospective, multicenter Kyoto Congestive Heart Failure (KCHF) Registry","volume":"82","author":"Yaku","year":"2018","journal-title":"Circ J"},{"key":"2026012113121386900_ehf215005-bib-0017","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-20-0947","article-title":"Clinical characteristics and outcomes of hospitalized patients with heart failure from the large-scale Japanese Registry of Acute Decompensated Heart Failure (JROADHF)","volume":"85","author":"Ide","year":"2021","journal-title":"Circ J"},{"key":"2026012113121386900_ehf215005-bib-0018","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1253\/circj.CJ-16-0837","article-title":"Correlation of pre- and in-hospital systolic blood pressure in acute heart failure patients and the prognostic implications - report from the Tokyo Cardiac Care Unit Network emergency medical service database","volume":"80","author":"Shiraishi","year":"2016","journal-title":"Circ J"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/11\/6\/4061\/64517011\/eschf_11_6_4061.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/11\/6\/4061\/64517011\/eschf_11_6_4061.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T18:14:11Z","timestamp":1769019251000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/11\/6\/4061\/8269369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,6]]},"references-count":18,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,8,6]]},"published-print":{"date-parts":[[2024,12,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.15005","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,12]]},"published":{"date-parts":[[2024,8,6]]},"assertion":[{"value":"2023-10-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}